These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 20890176

  • 21. Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.
    Zamanian RT, Gould MK.
    Curr Opin Pulm Med; 2008 Sep; 14(5):422-6. PubMed ID: 18664972
    [Abstract] [Full Text] [Related]

  • 22. Right-sided heart thromboembolism and pulmonary embolism.
    Iskandar SB, Shabaneh B, Brahmbhatt VR, Derian W, Whitaker J.
    Tenn Med; 2004 Jan; 97(1):34-6. PubMed ID: 14968686
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Severe refractory hypoxaemia in submassive pulmonary embolism: a surrogate marker of severe right ventricular dysfunction and indication for thrombolysis.
    Braude S, Martens-Nielsen J.
    Intern Med J; 2012 Jun; 42(6):712-5. PubMed ID: 22697154
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Fibrinolysis in pulmonary embolism].
    Thabut G, Jebrak G.
    Presse Med; 2001 Oct 20; 30(30):1501-6. PubMed ID: 11712211
    [Abstract] [Full Text] [Related]

  • 32. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
    Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G.
    J Am Coll Cardiol; 2017 Mar 28; 69(12):1536-1544. PubMed ID: 28335835
    [Abstract] [Full Text] [Related]

  • 33. Systemic Thrombolysis Therapy is Associated With Improved Outcomes Among Patients With Acute Pulmonary Embolism and Respiratory Failure.
    Koslow M, Epstein Shochet G, Fenadka F, Neuman Y, Osadchy A, Shitrit D.
    Am J Med Sci; 2020 Aug 28; 360(2):129-136. PubMed ID: 32466857
    [Abstract] [Full Text] [Related]

  • 34. Should thrombolytic therapy be used in patients with pulmonary embolism?
    Konstantinides S.
    Am J Cardiovasc Drugs; 2004 Aug 28; 4(2):69-74. PubMed ID: 15049719
    [Abstract] [Full Text] [Related]

  • 35. [Massive pulmonary embolism, thrombus in transit, and right ventricular dysfunction].
    Santos Martínez LE, Uriona Villarroel JE, Exaire Rodríguez JE, Mendoza D, Martínez Guerra ML, Pulido T, Bautista E, Castañón A, Sandoval J.
    Arch Cardiol Mex; 2007 Aug 28; 77(1):44-53. PubMed ID: 17500192
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluating status of thrombolysis in pulmonary embolism.
    Jain N.
    Indian Heart J; 2010 Aug 28; 62(1):92. PubMed ID: 21180048
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A clinical audit of thrombolytic therapy in patients with normotensive pulmonary embolism and intermediate risk.
    Nobre C, Mesquita D, Thomas B, Ponte T, Santos L, Tavares J.
    Acute Card Care; 2014 Jun 28; 16(2):63-6. PubMed ID: 24617753
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.